About: http://webisa.webdatacommons.org/366077284

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	As a purely clinical-stage company, it is very difficult to justify this $1.1 billion valuation, especially with investors pumping up the valuations of many oncology-based biotechs in anticipation of ASCO in two weeks.
http://www.w3.org/ns/prov#wasQuotedFrom	fool.com